Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript

Bioventus Inc. (NASDAQ:BVS) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET

Company Participants

David Crawford – Vice President of Investor Relations & Treasurer
Mark L. Singleton – Senior VP & CFO
Robert E. Claypoole – President, CEO & Director

Conference Call Participants

Caitlin Cronin – Canaccord Genuity Corp., Research Division
Chase Richard Knickerbocker – Craig-Hallum Capital Group LLC, Research Division
Junwoo Park – Cantor Fitzgerald & Co., Research Division
Robert Justin Marcus – JPMorgan Chase & Co, Research Division

Operator

Thank you for standing by. My name is Carly, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bioventus Inc. Second Quarter 2025 Earnings Conference Call. [Operator Instructions]

I would now like to turn the call over to Dave Crawford, Vice President, Investor Relations. Please go ahead.

David Crawford

Thanks, Carly, and good morning, everyone, and thanks for joining us. It’s my pleasure to welcome you to the Bioventus 2025 Second Quarter Earnings Conference Call. With me this morning are Rob Claypoole, President and CEO; and Mark Singleton, Senior Vice President and CFO. Rob will begin his remarks with an update on our business and our 2025 priorities. Then Mark will review our second quarter results and discuss our outlook, including our 2025 financial guidance. We will finish the call with Q&A. A presentation for today’s call is available on the Investors section of our website, bioventus.com.

But before we begin, I would like to remind everyone that our remarks today contain forward-looking statements that are based on the current market expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company’s filings with the Securities and Exchange Commission, including Item 1A